The News Scroll 17 September 2020  Last Updated at 6:36 pm | Source: PTI

Dr Reddy''s Laboratories extends gain, shares jump over 4 pc  

Dr Reddy''s Laboratories extends gain, shares jump over 4 pc  
outlookindia.com
1970-01-01T05:30:00+0530
New Delhi, Sep 17 (PTI) Shares of Dr Reddy''s Laboratories extended their gains and rose by over 4 per cent on Thursday as Russia''s sovereign wealth fund RDIF will supply 100 million (10 crore) doses of Sputnik V COVID-19 vaccine to the drug maker upon getting regulatory approval in India.

The stock gained 4.21 per cent to close at Rs 4,826.60 on the BSE. During the day, it jumped 4.60 per cent to a record high of Rs 4,845.

On the NSE, the scrip rose 4.30 per cent to close at Rs 4,827.25.

Shares of Dr Reddy''s Laboratories had gained over 4 per cent on Wednesday also.

The Russian Direct Investment Fund (RDIF) and Dr Reddy''s Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy''s said in a joint statement.

On August 11, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia and became the world''s first registered vaccine against COVID-19 based on the human adenoviral vectors platform.

Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India, the statement added.

It, however, did not provide any financial details of the agreement between the partners. PTI SUM RVK


Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI
Next Story : NCL employees take part in serological survey
Download the Outlook ​Magazines App. Six magazines, wherever you go! Play Store and App Store